Wonbiogen Statistics

Total Valuation

Wonbiogen has a market cap or net worth of KRW 44.62 billion. The enterprise value is 37.06 billion.

Market Cap	44.62B
Enterprise Value	37.06B

Important Dates

The last earnings date was Friday, November 8, 2024.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	n/a

Share Statistics

Wonbiogen has 35.47 million shares outstanding. The number of shares has increased by 1.35% in one year.

Current Share Class	n/a
Shares Outstanding	35.47M
Shares Change (YoY)	+1.35%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	32.42%
Owned by Institutions (%)	n/a
Float	23.97M

Valuation Ratios

The trailing PE ratio is 8.86.

PE Ratio	8.86
Forward PE	n/a
PS Ratio	1.51
PB Ratio	1.25
P/TBV Ratio	n/a
P/FCF Ratio	6.67
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.58, with an EV/FCF ratio of 5.54.

EV / Earnings	6.88
EV / Sales	1.26
EV / EBITDA	4.58
EV / EBIT	5.75
EV / FCF	5.54

Financial Position

The company has a current ratio of 2.92, with a Debt / Equity ratio of 0.18.

Current Ratio	2.92
Quick Ratio	2.15
Debt / Equity	0.18
Debt / EBITDA	0.81
Debt / FCF	0.98
Interest Coverage	101.06

Financial Efficiency

Return on equity (ROE) is 16.39% and return on invested capital (ROIC) is 10.05%.

Return on Equity (ROE)	16.39%
Return on Assets (ROA)	9.37%
Return on Capital (ROIC)	10.05%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.68
Inventory Turnover	2.26

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.00% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-24.00%
50-Day Moving Average	1,352.32
200-Day Moving Average	1,585.44
Relative Strength Index (RSI)	30.75
Average Volume (20 Days)	90,451

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Wonbiogen had revenue of KRW 29.30 billion and earned 5.39 billion in profits. Earnings per share was 141.98.

Revenue	29.30B
Gross Profit	14.17B
Operating Income	6.50B
Pretax Income	6.80B
Net Income	5.39B
EBITDA	8.15B
EBIT	6.50B
Earnings Per Share (EPS)	141.98

Full Income Statement

Balance Sheet

The company has 14.45 billion in cash and 6.58 billion in debt, giving a net cash position of 7.87 billion or 221.74 per share.

Cash & Cash Equivalents	14.45B
Total Debt	6.58B
Net Cash	7.87B
Net Cash Per Share	221.74
Equity (Book Value)	35.91B
Book Value Per Share	1,006.42
Working Capital	17.05B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.88 billion and capital expenditures -1.19 billion, giving a free cash flow of 6.69 billion.

Operating Cash Flow	7.88B
Capital Expenditures	-1.19B
Free Cash Flow	6.69B
FCF Per Share	188.55

Full Cash Flow Statement

Margins

Gross margin is 48.35%, with operating and profit margins of 22.19% and 18.38%.

Gross Margin	48.35%
Operating Margin	22.19%
Pretax Margin	23.19%
Profit Margin	18.38%
EBITDA Margin	27.82%
EBIT Margin	22.19%
FCF Margin	22.83%

Dividends & Yields

This stock pays an annual dividend of 20.00, which amounts to a dividend yield of 1.62%.

Dividend Per Share	20.00
Dividend Yield	1.62%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	13.17%
Buyback Yield	-1.35%
Shareholder Yield	0.26%
Earnings Yield	11.29%
FCF Yield	14.99%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Wonbiogen has an Altman Z-Score of 6.02.

Altman Z-Score	6.02
Piotroski F-Score	n/a